| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.33 | 4e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-10 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-10 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.33 | 9e-09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |